Antares Pharma ATRS today announced positive results
from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX). The
clinical trial was conducted as a multi-center, open-label, single-arm,
in-clinic study to evaluate the actual human use of methotrexate
administered via the VIBEX Medi-Jet in adult patients with rheumatoid
arthritis (RA).
The study assessed the safe usability of VIBEX MTX for
self-administration of parenteral MTX in adult RA patients after
standardized training by site personnel and review of written
instructions. Secondary objectives included evaluation of the
reliability, ease of use and robustness of the VIBEX Medi-Jet; assess
the safety and local tolerance of Medi-Jet administered MTX and to
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in